Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Defining Endpoints in Becker Muscular Dystrophy

NCT05257473 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT05257473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05257473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Defining Endpoints in Becker Muscular Dystrophy
Lead sponsor
Virginia Commonwealth University
Phase
Observational
Overall status
Active, not recruiting
Start date
April 13, 2022
Completion date
September 30, 2026
Enrollment
80 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

becker muscular dystrophy, muscular dystrophies, muscular dystrophy in children, muscular dystrophy, becker